News and media about our research and other web resources for stem cells.
October 15, 2013
Patients with Peripheral Artery Disease being Recruited for Clinical Trial
Doctors and researchers at THI are recruiting patients who suffer from peripheral artery disease (PAD) for a new clinical trial to assess the benefits and risks in the use of adult stem cells from patients' own bone marrow to treat leg pain commonly associated with the disease.
Read more ...
August 21, 2013
McNair Foundation Names Dr.
Emerson Perin THI McNair Scholar
Emerson Perin, director of the Stem Cell Center, has been named a McNair
Scholar at THI. The
Robert and Janice McNair Foundation established the McNair Medical Institute
and the McNair Scholars Program to recognize and support the work of outstanding
scientists and physicians.
Read more ...
May 29, 2013
FDA-Approved Clinical Trial to Test Effectiveness of Fat-Derived Regenerative Cells
Doctors at the Texas Heart Institute announced that they have performed an investigational procedure on six patients in a new FDA-approved clinical trial (ATHENA) to evaluate therapy that uses regenerative cells derived from a patients' own adipose (body fat) tissue to treat a severe form of heart failure. Read more ...
Texas Heart Institute Stem Cell Center is now cited by National Institutes of Health (NIH) in its list of "Research Programs at Universities and Institutions." See the section on Other Online Resources at the NIH Stem Cell Information website.
Texas Heart Institute has been chosen as the
Biorepository Core Lab for the national network of
cardiovascular stem cell research centers, the Cardiovascular Cell Therapy
Research Network (CCTRN).As the biorepository for the Network, THI will
store, catalog and make available for approved research adult stem cells to
laboratories throughout the nation. The Biorepository Core is directed by Doris
A. Taylor, PhD, Director of Regenerative Medicine Research at THI at St. Luke’s,
and Adrian P. Gee, PhD, Professor of Medicine and Pediatrics and Director of the
Center for Cell and Gene Therapy at Baylor College of Medicine. (News release December
July 5, 2012
FOCUS trial in the spotlight again
Dr. Emerson Perin discusses FOCUS with Dr. Alexandra Lansky (Yale University, New Haven, CT) for the Trials and PIs series. Filmed for theheart.org at ACC in 2012. Watch the video on YouTube. Learn more about the clinical trial on this website.
June 14, 2012
Inside a beating heart
"Imagine a day when human organs could be regenerated using one's own stem cells or those donated from other adults. Scientists are making progress toward that day". Dr. James Willerson, president and medical director of THI shares a bit of stem cell research history.
From the Ladue News, St. Louis, Missouri.
Act 2 Opens for Stem Cell Heart Treatments
Medical Director of THI's Stem Cell Center, Dr. Emerson Perin, is featured in the lead story of Cardiology News.
"Stem cell treatment for cardiac disease recently launched into
advanced clinical trials, as a flurry of early-phase studies over the
last year has collectively confirmed the treatment as safe but left its
efficacy unresolved." Read more at ecardiology.com.
April 3, 2012
The National Institutes of Health Extends National Cardiovascular Cell Therapy Research Network (CCTRN)
The national Cardiovascular Cell Therapy Research Network (CCTRN), which includes Texas Heart Institute, will be expanded and has been refunded for an additional seven years by the National Institutes of Health (NIH).
March 24, 2012
Study Shows Potential for Stem Cell Therapy in Patients Suffering from Heart Failure
Novel treatment may help restore heart's ability to pump
THI doctors presented at the American College of Cardiology's 61st Annual Scientific Session, the results of a multi-center clinical study that measured the possible benefits of using a patient's own bone marrow cells to repair damaged areas of the heart. The study, the largest such investigation to date, found that the hearts of patients receiving bone-marrow derived stem cells showed a small but significant increase in the ability to pump oxygenated blood from the left ventricle. "This is exactly the kind of information we need to move forward with the clinical use of stem cell therapy," said THI's Dr. Emerson Perin. The study was conducted by the Cardiovascular Cell Therapy Research Network (CCTRN).
March 15, 2012Other Web Resources
Cytomedix, Inc. Announces Publication in American Heart Journal Highlighting Positive Phase I Clinical Data Using ALD-201 to Treat Ischemic Heart Failure
Emerson C. Perin, MD, PhD, Medical Director of THI's Stem Cell Center, noted, "The preliminary evidence suggests improved perfusion and a trend toward improved functional capacity in no-option heart failure patients treated with ALDHbr cells." Read the full press release from Cytomedix.
The National Institutes of Health resource for stem cell research
See Publications for articles and presentations by Stem Cell Center physician/scientists.
Updated July 2014